Categoria Pfizer

LIPITOR – PRESCRIBING INFORMATION

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is recommended as an adjunct to diet when the response to…

LEVOXYL – PRESCRIBING INFORMATION

Hypothyroidism LEVOXYL is indicated in pediatric and adult patients as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression LEVOXYL is indicated in pediatric and adult patients as…

ACCUPRIL – PRESCRIBING INFORMATION

WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue ACCUPRIL as soon as possible. • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See Warnings: Fetal Toxicity INDICATIONS AND USAGE Hypertension…

ABRILADA – PRESCRIBING INFORMATION

ABRILADA- adalimumab-afzb ABRILADA- adalimumab-afzb injection, solution Pfizer Laboratories Div Pfizer Inc Instructions for Use — Single-dose Prefilled Pen and Single-dose Prefilled Syringe ———- INSTRUCTIONS FOR USE ABRILADA (AH brill-ah-dah)(adalimumab-afzb)40 mg mLSingle-dose Prefilled PenInjection, for subcutaneous (under the skin) use Keep…